An open-label, randomized and multi-center clinical trial to evaluate the efficacy of Silibinin in preventing drug-induced liver injury.
Int J Clin Exp Med
; 8(3): 4320-7, 2015.
Article
in En
| MEDLINE
| ID: mdl-26064348
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
Language:
En
Journal:
Int J Clin Exp Med
Year:
2015
Type:
Article